Completed NA INTERVENTIONAL NCT01663376

Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cells Implantation in Patients With Critical Limb Ischemia

Effects of Adipose Tissue Derived Stem Cells Implantation in Patients With Critical Limb Ischemia

Sponsor: Pusan National University Hospital

Interventions Autologous Adipose Tissue derived MSCs Transplantation

Updated 7 times since 2017 Last updated: Jun 3, 2019 Started: Jan 31, 2009 Primary completion: Mar 31, 2010 Completion: Apr 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01663376, this NA trial focuses on Critical Limb Ischemia and remains completed. Sponsored by Pusan National University Hospital, it has been updated 7 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jul 2019 — Jan 2021 [monthly]

Completed NA

Phase: PHASE1_PHASE2 → NA

▶ Show 2 earlier versions

Jun 2018 — Jul 2019 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pusan National University Hospital
R-Bio

Data source: R-Bio

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pusan, South Korea